[Mendelian susceptibility to mycobacterial disease: defects in the IL-12/IFNgamma pathway]

Claire Fieschi1

  • 1Département d'immunologie, Unité d'immunopathologie, Hôpital Saint-Louis, AP-HP, Paris (75). claire.fieschi@sls.aphp.fr

Presse Medicale (Paris, France : 1983)
|May 20, 2006
PubMed

Insights

Mendelian susceptibility to mycobacterial disease involves genetic defects in the interferon gamma/interleukin 12 pathway, leading to infections in healthy individuals. Understanding these genetic mutations aids in comprehending immune responses to mycobacteria and tuberculosis.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Context:

  • Mendelian susceptibility to mycobacterial disease (MSMD) is a rare genetic disorder.
  • It causes disseminated infections from normally non-virulent mycobacteria and non-typhoid Salmonella in healthy individuals.
  • MSMD is linked to mutations in genes crucial for the interferon gamma (IFNγ)/interleukin 12 (IL-12) signaling pathway.

Purpose:

  • To describe Mendelian susceptibility to mycobacterial disease.
  • To highlight the genetic basis and molecular mechanisms underlying these conditions.
  • To explore the role of the IFNγ/IL-12 pathway in host defense against mycobacteria and Salmonella.

Summary:

  • MSMD encompasses 12 distinct diseases caused by mutations in 5 genes within the IFNγ/IL-12 immune response loop.
  • Defects in IFNγ pathway signaling predispose individuals to mycobacterial infections.
  • Defects in IL-12 pathway signaling increase susceptibility to systemic non-typhoid salmonellosis, with tuberculosis observed in both pathway defects.

Impact:

  • Elucidating the genetic basis of MSMD enhances understanding of the human immune system's response to mycobacteria.
  • This research provides insights into the genetic underpinnings of tuberculosis and other granulomatous diseases.
  • Identifying genetic defects can inform future diagnostic and therapeutic strategies for infectious diseases.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...